IMR Press / RCM / Volume 14 / Issue 2-4 / DOI: 10.3909/ricm0649
Open Access Review
An Update on Endovascular Management of Acute Thoracic Aortic Disease and Future Directions
Show Less
1 Division of Cardiothoracic Surgery, Cedars Sinai Medical Center, Los Angeles, CA
2 Division of Vascular Surgery and Endovascular Therapy, Baylor College of Medicine, Houston, TX
Rev. Cardiovasc. Med. 2013 , 14(2-4), 99–106; https://doi.org/10.3909/ricm0649
Published: 30 June 2013
Abstract
Thoracic endovascular aortic repair (TEVAR) has become an alternative treatment option for acute thoracic aortic disease. This review focuses on current endovascular treatment of acute thoracic aortic disease and future directions of TEVAR. TEVAR is a promising alternative approach to open surgery, with lower early mortality and morbidity rates, especially in high-risk cohorts. Furthermore, with accumulating experience and improving device technology and imaging modalities, TEVAR has become safer and has potential to expand treatment options to include ascending and arch pathologies.
Keywords
Thoracic endovascular aortic repair
Acute aortic dissection
Thoracic descending aneurysm
Stent graft
Share
Back to top